Israel Englander Becton Dickinson & CO Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Millennium Management LLC holds 234,800 shares of BDX stock, worth $53.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

234,800

Previous 1,614,996 85.46%

Holding current value

$53.3 Million

Previous $377 Million 85.0%

% of portfolio

0.03%

Previous 0.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $259 Million - $283 Million	-1,168,794 Reduced 72.37%	446,202 $108 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $286 Million - $313 Million	1,271,629 Added 370.34%	1,614,996 $377 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $63.5 Million - $67.4 Million	271,920 Added 380.59%	343,367 $85 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $57.7 Million - $66.4 Million	-248,548 Reduced 77.67%	71,447 $17.4 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $212 Million - $236 Million	-890,226 Reduced 73.56%	319,995 $84.5 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $107 Million - $121 Million	466,266 Added 62.67%	1,210,221 $300 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $88.6 Million - $104 Million	405,917 Added 120.08%	743,955 $189 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $16.1 Million - $83.6 Million	316,260 Added 1452.2%	338,038 $75.3 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $8.42 Million - $9.88 Million	-35,859 Reduced 62.22%	21,778 $5.37 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $12.3 Million - $13.6 Million	-50,419 Reduced 46.66%	57,637 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $8.21 Million - $8.95 Million	-35,668 Reduced 24.82%	108,056 $27.2 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $7.18 Million - $7.91 Million	30,856 Added 27.34%	143,724 $35.3 Million
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $22 Million - $24.1 Million	94,495 Added 514.31%	112,868 $27.4 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $140 Million - $155 Million	-603,515 Reduced 97.05%	18,373 $4.47 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $122 Million - $136 Million	551,938 Added 789.05%	621,888 $156 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $3.03 Million - $3.89 Million	-14,058 Reduced 16.73%	69,950 $16.3 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $114 Million - $137 Million	-518,215 Reduced 86.05%	84,008 $20.1 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $90.1 Million - $102 Million	381,180 Added 172.45%	602,223 $164 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $33 Million - $36.6 Million	142,914 Added 182.92%	221,043 $55.9 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $15.1 Million - $17.1 Million	69,508 Added 806.26%	78,129 $793,000
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $39.3 Million - $47.3 Million	-190,536 Reduced 95.67%	8,621 $2.15 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $38.7 Million - $48.7 Million	188,819 Added 1826.46%	199,157 $44.9 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $9.04 Million - $9.93 Million	-38,797 Reduced 78.96%	10,338 $2.7 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $46.6 Million - $54.5 Million	-226,770 Reduced 82.19%	49,135 $10.6 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $9.11 Million - $10.7 Million	-48,191 Reduced 14.87%	275,905 $59.1 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $60.6 Million - $64.5 Million	324,096	324,096 $63.5 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account